 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Sio Gene Therapies Inc. (SIOX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-03-18 Purchase | 2019-03-19 5:15 pm | Axovant Sciences Ltd. | AXON | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner | 6,666,667 | $1.5 | $10,000,001 | 105,952,384 (Indirect) | View |
| 2019-06-14 Purchase | 2019-06-17 7:05 pm | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 3,370 | $5.2212 | $17,595 | 3,370 (Direct) | View |
| 2019-06-14 Purchase | 2019-06-17 7:09 pm | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan CEO | 7,500 | $5.21 | $39,075 | 7,500 (Direct) | View |
| 2020-02-24 Purchase | 2020-02-27 7:49 pm | Axovant Gene Therapies Ltd. | AXGT | Roivant Sciences Ltd. 10% Owner | 5,333,333 | $3.75 | $19,999,999 | 18,577,380 (Direct) | View |
| 2020-03-16 Purchase | 2020-03-18 8:20 pm | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 10,000 | $1.7844 | $17,844 | 13,370 (Indirect) | View |
| 2020-07-08 Purchase | 2020-07-10 6:11 pm | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 37,500 | $2.737 | $102,637 | 57,836 (Direct) | View |
| 2020-07-08 Purchase | 2020-07-10 6:12 pm | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 10,000 | $2.729 | $27,290 | 23,370 (Indirect) | View |
| 2020-11-24 Purchase | 2020-11-25 9:07 pm | Sio Gene Therapies Inc. | SIOX | Pande Atul Director | 10,000 | $2.3399 | $23,399 | 33,370 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-04-15 Option Award | 2019-04-17 9:11 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | JEFFS ROGER Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:13 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Bazley Mathew C. General Counsel | 726,000 | $1.06 | 250,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:13 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Bazley Mathew C. General Counsel | 250,000 | $1.06 | 250,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:14 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Cheruvu Pavan CEO | 1,596,000 | $1.06 | 1,596,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:14 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Cheruvu Pavan CEO | 1,596,000 | $1.06 | 1,596,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:15 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Modig Berndt Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:17 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Corcoran Gavin VP | 767,000 | $1.06 | 200,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:17 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Corcoran Gavin VP | 200,000 | $1.06 | 200,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:18 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Torti Frank Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:19 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | POTTER MYRTLE S Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:20 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Bickerstaff George Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:21 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | Pande Atul Director | 255,000 | $1.06 | 255,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 6:06 pm | N/A 2029-06-26 | Axovant Gene Therapies Ltd. | AXGT | Sundaram Senthil Vel Director | 18,750 | $6.19 | 18,750 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 6:15 pm | N/A 2029-06-30 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 150,000 | $6.42 | 75,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 6:15 pm | N/A 2029-06-30 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 75,000 | $6.42 | 75,000 (Direct) | View |
| 2019-09-21 Option Award | 2019-09-24 5:14 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer | 45,181 | $0 | 45,181 (Direct) | View |
| 2019-09-21 Option Award | 2019-09-24 5:15 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 30,120 | $0 | 30,120 (Direct) | View |
| 2019-09-21 Option Award | 2019-09-24 5:15 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin VP | 32,003 | $0 | 32,003 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 8:59 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 169,100 | $3.45 | 112,700 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 8:59 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 112,700 | $0 | 112,700 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:01 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 78,900 | $3.45 | 52,600 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:01 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 52,600 | $0 | 52,600 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:04 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin VP | 63,700 | $3.45 | 42,400 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:04 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin VP | 42,400 | $0 | 42,400 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:06 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Sundaram Senthil Vel Director | 17,500 | $3.45 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:07 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Torti Frank Director | 17,500 | $3.45 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:09 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director | 17,500 | $3.45 | 17,500 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:10 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Modig Berndt Director | 17,500 | $3.45 | 17,500 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 16,001 (Direct) | View |
| 2020-06-12 Tax Withholding | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 6,211 | $3.46 | 16,001 (Direct) | View |
| 2020-06-12 Disposition | 2020-06-15 7:38 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer | 16,002 | $0 | 16,001 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 22,591 | $0 | 22,590 (Direct) | View |
| 2020-06-11 Tax Withholding | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 9,755 | $3.09 | 22,590 (Direct) | View |
| 2020-06-11 Disposition | 2020-06-15 7:39 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Director | 22,591 | $0 | 22,590 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 15,060 (Direct) | View |
| 2020-06-15 Tax Withholding | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 5,266 | $3.25 | 15,060 (Direct) | View |
| 2020-06-15 Disposition | 2020-06-15 7:40 pm | N/A N/A | Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer | 15,060 | $0 | 15,060 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-07 9:28 pm | N/A 2030-10-04 | Axovant Gene Therapies Ltd. | AXGT | Vuori Kristiina MD Director | 35,000 | $5.63 | 35,000 (Direct) | View |